Please note that CompuGroup Medical's price fluctuation is risky at this time. Calculation of the real value of CompuGroup Medical is based on 3 months time horizon. Increasing CompuGroup Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CompuGroup stock is determined by what a typical buyer is willing to pay for full or partial control of CompuGroup Medical AG. Since CompuGroup Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CompuGroup Stock. However, CompuGroup Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical
Market 16.22
Real 15.13
Hype 16.22
The intrinsic value of CompuGroup Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CompuGroup Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CompuGroup Medical AG helps investors to forecast how CompuGroup stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CompuGroup Medical more accurately as focusing exclusively on CompuGroup Medical's fundamentals will not take into account other important factors:
CompuGroup Medical AG is presently projected to have takeover price of 1.94 B with market capitalization of 2.01 B, debt of 879.99 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the CompuGroup Medical fundamentals before making investing decisions based on enterprise value of the company
About 56.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. CompuGroup Medical AG is performing exceptionally good at this time. It has a great probability to report excellent financial results in April.
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CompuGroup Medical has an asset utilization ratio of 58.71 percent. This implies that the Company is making USD0.59 for each dollar of assets. An increasing asset utilization means that CompuGroup Medical AG is more efficient with each dollar of assets it utilizes for everyday operations.
Credit Downgrade
Yuan Drop
Covid
CompuGroup Medical Ownership Allocation
CompuGroup Medical holds a total of 49.56 Million outstanding shares. CompuGroup Medical AG retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
CompuGroup Medical Profitability Analysis
The company reported the revenue of 1.15 B. Net Income was 34.76 M with profit before overhead, payroll, taxes, and interest of 402.03 M.
About CompuGroup Medical Valuation
The stock valuation mechanism determines CompuGroup Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of CompuGroup Medical based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of CompuGroup Medical. We calculate exposure to CompuGroup Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CompuGroup Medical's related companies.
When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.